305 related articles for article (PubMed ID: 37478398)
21. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
22. MECOM Deficiency: from Bone Marrow Failure to Impaired B-Cell Development.
Voit RA; Sankaran VG
J Clin Immunol; 2023 Aug; 43(6):1052-1066. PubMed ID: 37407873
[TBL] [Abstract][Full Text] [Related]
23. Biology and clinical management of hypoplastic MDS: MDS as a bone marrow failure syndrome.
Karantanos T; DeZern AE
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101280. PubMed ID: 34404534
[TBL] [Abstract][Full Text] [Related]
24. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
[TBL] [Abstract][Full Text] [Related]
25. Clonality in context: hematopoietic clones in their marrow environment.
Cooper JN; Young NS
Blood; 2017 Nov; 130(22):2363-2372. PubMed ID: 29046282
[TBL] [Abstract][Full Text] [Related]
26. Macrophage TNF-α licenses donor T cells in murine bone marrow failure and can be implicated in human aplastic anemia.
Sun W; Wu Z; Lin Z; Hollinger M; Chen J; Feng X; Young NS
Blood; 2018 Dec; 132(26):2730-2743. PubMed ID: 30361263
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
Cuccuini W; Collonge-Rame MA; Auger N; Douet-Guilbert N; Coster L; Lafage-Pochitaloff M
Curr Res Transl Med; 2023; 71(4):103423. PubMed ID: 38016422
[TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure.
Javier J; Hinge A; Bartram J; Xu J; Filippi MD
Haematologica; 2022 Jun; 107(6):1323-1334. PubMed ID: 34706493
[TBL] [Abstract][Full Text] [Related]
29. [Bone marrow failure and TP53 activating mutations].
Ito E
Rinsho Ketsueki; 2022; 63(9):1115-1125. PubMed ID: 36198537
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow failure and extramedullary hematopoiesis in McCune-Albright syndrome.
Robinson C; Boyce AM; Estrada A; Kleiner DE; Mathew R; Stanton R; Frangoul H; Collins MT
Osteoporos Int; 2018 Jan; 29(1):237-241. PubMed ID: 29071359
[TBL] [Abstract][Full Text] [Related]
31. Prolonged bone marrow failure with monosomy 7 after engraftment failure following bone marrow transplantation.
Kobayashi R; Arioka H; Yoshida M; Cho Y; Iguchi A; Kaneda M; Shikano T
Int J Hematol; 2001 Feb; 73(2):258-61. PubMed ID: 11372741
[TBL] [Abstract][Full Text] [Related]
32. Introduction to Acquired and Inherited Bone Marrow Failure.
Sieff CA
Hematol Oncol Clin North Am; 2018 Aug; 32(4):569-580. PubMed ID: 30047411
[TBL] [Abstract][Full Text] [Related]
33. Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.
Li HS; Jin J; Liang X; Matatall KA; Ma Y; Zhang H; Ullrich SE; King KY; Sun SC; Watowich SS
Eur J Haematol; 2016 Sep; 97(3):261-70. PubMed ID: 26660446
[TBL] [Abstract][Full Text] [Related]
34. Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes.
Koldej RM; Prabahran A; Tan CW; Ludford-Menting M; Morgan H; Holzwart N; Davis MJ; Ritchie DS
Front Immunol; 2023; 14():1213560. PubMed ID: 37818364
[TBL] [Abstract][Full Text] [Related]
35. Genomic insult oriented mitochondrial instability and proliferative hindrance in the bone marrow of aplastic mice including stem/progenitor population.
Chatterjee R; Law S
Pathol Res Pract; 2019 Apr; 215(4):784-793. PubMed ID: 30683472
[TBL] [Abstract][Full Text] [Related]
36. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes (Review).
Votavova H; Belickova M
Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34958107
[TBL] [Abstract][Full Text] [Related]
37. Function and malfunction of hematopoietic stem cells in primary bone marrow failure syndromes.
Risitano AM; Maciejewski JP; Selleri C; Rotoli B
Curr Stem Cell Res Ther; 2007 Jan; 2(1):39-52. PubMed ID: 18220891
[TBL] [Abstract][Full Text] [Related]
38. Analysis of T-cell clonality in bone marrow of patients with acquired aplastic anaemia.
Melenhorst JJ; Fibbe WE; Struyk L; van der Elsen PJ; Willemze R; Landegent JE
Br J Haematol; 1997 Jan; 96(1):85-91. PubMed ID: 9012692
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin is highly effective in murine models of immune-mediated bone marrow failure.
Feng X; Lin Z; Sun W; Hollinger MK; Desierto MJ; Keyvanfar K; Malide D; Muranski P; Chen J; Young NS
Haematologica; 2017 Oct; 102(10):1691-1703. PubMed ID: 28729300
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic development: a gap in our understanding of inherited bone marrow failure.
Kurre P
Exp Hematol; 2018 Mar; 59():1-8. PubMed ID: 29248612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
